<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The loss of the epithelial architecture and cell polarity/differentiation is known to be important during the tumorigenic process </plain></SENT>
<SENT sid="1" pm="."><plain>Here we demonstrate that the brush border protein Myosin Ia (MYO1A) is important for polarization and differentiation of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells and is frequently inactivated in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> by genetic and epigenetic mechanisms </plain></SENT>
<SENT sid="2" pm="."><plain>MYO1A frame-shift mutations were observed in 32% (37 of 116) of the <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> with microsatellite instability analyzed, and evidence of promoter methylation was observed in a significant proportion of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines and primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The loss of polarization/differentiation resulting from MYO1A inactivation is associated with higher <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in soft agar and in a <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the progression of genetically and carcinogen-initiated <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumors</z:e> was significantly accelerated in Myo1a knockout mice compared with Myo1a <z:mp ids='MP_0002169'>wild-type</z:mp> animals </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, MYO1A <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> expression was found to be an independent prognostic factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with low MYO1A <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> protein levels had significantly shorter disease-free and overall survival compared with patients with high tumoral MYO1A (logrank test P = 0.004 and P = 0.009, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>The median time-to-disease recurrence in patients with low MYO1A was 1 y, compared with &gt;9 y in the group of patients with high MYO1A </plain></SENT>
<SENT sid="8" pm="."><plain>These results identify MYO1A as a unique <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor gene in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and demonstrate that the loss of structural brush border proteins involved in cell polarity are important for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development </plain></SENT>
</text></document>